comparemela.com

Latest Breaking News On - Nasdaq zntl - Page 1 : comparemela.com

abrdn plc Makes New Investment in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)

Abrdn plc purchased a new stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 40,156 shares of the company’s stock, valued at approximately $608,000. abrdn plc owned about 0.06% of Zentalis Pharmaceuticals as […]

Melissab-epperly
Exchange-commission
Hermes-inc
Insider-transactions-at-zentalis-pharmaceuticals
News-ratings-for-zentalis-pharmaceuticals-daily
Eventide-asset-management
Sectoral-asset-management-inc
Quarter-for-zentalis-pharmaceuticals
Vanguard-group-inc
Zentalis-pharmaceuticals-stock-down
Nasdaq

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Trading Down 7.1%

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) fell 7.1% during mid-day trading on Wednesday . The company traded as low as $11.63 and last traded at $11.68. 445,154 shares were traded during mid-day trading, a decline of 44% from the average session volume of 791,847 shares. The stock had previously closed at […]

Wellington
New-zealand-general
New-zealand
Melissab-epperly
Eventide-asset-management
Hermes-inc
Zentalis-pharmaceuticals
Zentalis-pharmaceuticals-inc
Zentalis-pharmaceuticals-stock-down
Wellington-management-group
Institutional-trading-of-zentalis-pharmaceuticals

Analysts Set Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Target Price at $38.57

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven ratings firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average […]

China
Melissab-epperly
Securities-exchange-commission
Exchange-traded-concepts
Zentalis-pharmaceuticals-stock
China-universal-asset-management-co
Quest-partners
Nasdaq
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-inc
Analyst-recommendations-for-zentalis-pharmaceuticals

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives $38.57 Consensus Price Target from Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has been given an average rating of “Moderate Buy” by the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year […]

Melissab-epperly
Insider-transactions-at-zentalis-pharmaceuticals
Decheng-capital
Zentalis-pharmaceuticals-price-performance
Nasdaq
Institutional-investors-weigh-in-on-zentalis-pharmaceuticals
News-ratings-for-zentalis-pharmaceuticals-daily
Vanguard-group-inc
Rafferty-asset-management
Zentalis-pharmaceuticals-inc
Hermes-inc

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Trading Up 6.3%

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report)’s stock price was up 6.3% during mid-day trading on Tuesday . The company traded as high as $15.66 and last traded at $15.54. Approximately 105,881 shares changed hands during trading, a decline of 87% from the average daily volume of 796,470 shares. The stock had previously closed […]

China
Melissab-epperly
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-stock-down
Quest-partners
Us-bancorp
Securities-exchange-commission
Zentalis-pharmaceuticals
Zentalis-pharmaceuticals-inc
Institutional-investors-weigh-in-on-zentalis-pharmaceuticals
China-universal-asset-management-co

vimarsana © 2020. All Rights Reserved.